Literature DB >> 29076169

International Forum on GMP-grade human platelet lysate for cell propagation: summary.

D Strunk1, M Lozano2, D C Marks, Y S Loh, G Gstraunthaler, H Schennach, E Rohde, S Laner-Plamberger, M Öller, J Nystedt, R Lotfi, M Rojewski, H Schrezenmeier, K Bieback, R Schäfer, T Bakchoul, M Waidmann, S M Jonsdottir-Buch, H Montazeri, O E Sigurjonsson, P Iudicone, D Fioravanti, L Pierelli, M Introna, C Capelli, A Falanga, M Takanashi, O Lόpez-Villar, T Burnouf, J A Reems, J Pierce, A M Preslar, K Schallmoser3.   

Abstract

Entities:  

Year:  2017        PMID: 29076169     DOI: 10.1111/vox.12593

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  14 in total

Review 1.  Platelet lysate for COVID-19 pneumonia-a newer adjunctive therapeutic avenue.

Authors:  Madhan Jeyaraman; Sathish Muthu; Manish Khanna; Rashmi Jain; Talagavadi Channaiah Anudeep; Purushothaman Muthukanagaraj; Sushmitha Eachagattada Siddesh; Arun Gulati; Ajay Shringeri Satish; Naveen Jeyaraman; Venus Khanna
Journal:  Stem Cell Investig       Date:  2021-06-08

2.  [Standardized management of platelet derivatives for tissue regeneration research and applications].

Authors:  Xingqin Xie; Yi Zhang; Xinxin Zhao; Tongxin Liu; Liping Sun
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-03-15

3.  Comparative Analysis of Different Platelet Lysates and Platelet Rich Preparations to Stimulate Tendon Cell Biology: An In Vitro Study.

Authors:  Franka Klatte-Schulz; Tanja Schmidt; Melanie Uckert; Sven Scheffler; Ulrich Kalus; Markus Rojewski; Hubert Schrezenmeier; Axel Pruss; Britt Wildemann
Journal:  Int J Mol Sci       Date:  2018-01-10       Impact factor: 5.923

4.  Human Platelet Lysate Improves Bone Forming Potential of Human Progenitor Cells Expanded in Microcarrier-Based Dynamic Culture.

Authors:  Priyanka Gupta; Gabriella Nilsson Hall; Liesbet Geris; Frank P Luyten; Ioannis Papantoniou
Journal:  Stem Cells Transl Med       Date:  2019-04-30       Impact factor: 6.940

5.  Evaluation of platelet lysate as a substitute for FBS in explant and enzymatic isolation methods of human umbilical cord MSCs.

Authors:  Sangeetha Kandoi; Praveen Kumar L; Bamadeb Patra; Prasanna Vidyasekar; Divya Sivanesan; Vijayalakshmi S; Rajagopal K; Rama Shanker Verma
Journal:  Sci Rep       Date:  2018-08-20       Impact factor: 4.379

Review 6.  Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?

Authors:  Martino Introna; Josée Golay
Journal:  Front Immunol       Date:  2020-12-11       Impact factor: 7.561

7.  Human Platelet Lysate Can Replace Fetal Calf Serum as a Protein Source to Promote Expansion and Osteogenic Differentiation of Human Bone-Marrow-Derived Mesenchymal Stromal Cells.

Authors:  Maria Karadjian; Anne-Sophie Senger; Christopher Essers; Sebastian Wilkesmann; Raban Heller; Joerg Fellenberg; Rolf Simon; Fabian Westhauser
Journal:  Cells       Date:  2020-04-09       Impact factor: 6.600

8.  Effects of amotosalen treatment on human platelet lysate bioactivity: A proof-of-concept study.

Authors:  Christian Christensen; Sandra Mjoll Jonsdottir-Buch; Olafur Eysteinn Sigurjonsson
Journal:  PLoS One       Date:  2020-04-15       Impact factor: 3.240

9.  Upregulation of mitotic bookmarking factors during enhanced proliferation of human stromal cells in human platelet lysate.

Authors:  Sandra Laner-Plamberger; Michaela Oeller; Cornelia Mrazek; Arnulf Hartl; Alina Sonderegger; Eva Rohde; Dirk Strunk; Katharina Schallmoser
Journal:  J Transl Med       Date:  2019-12-30       Impact factor: 5.531

10.  Influence of platelet storage time on human platelet lysates and platelet lysate-expanded mesenchymal stromal cells for bone tissue engineering.

Authors:  Siddharth Shanbhag; Samih Mohamed-Ahmed; Turid Helen Felli Lunde; Salwa Suliman; Anne Isine Bolstad; Tor Hervig; Kamal Mustafa
Journal:  Stem Cell Res Ther       Date:  2020-09-23       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.